このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Early Time-Restricted Eating in Young Judo Athletes (TRE-JUDO)

2026年6月25日 更新者:Maha Gasmi、University of Manouba

Effects of a 5-Month Early Time-Restricted Eating Protocol on Body Composition, Muscle Damage Biomarkers, Competitive Anxiety, and Self-Confidence in Highly Trained Young Judo Athletes: A Randomized Controlled Trial

This study investigates the effects of a 5-month early time-restricted eating (e-TRE) intervention on body composition, muscle damage biomarkers, and psychological variables in highly trained young male judo athletes. One hundred participants were randomly assigned to either an e-TRE group or a control group. The e-TRE group followed a 16:8 fasting protocol (07:00-15:00 eating window) while maintaining their usual training program, whereas the control group maintained habitual dietary patterns. Outcomes included changes in body composition (BMI, body fat, skeletal muscle mass), muscle damage biomarkers (CK, LDH, ASAT, ALAT, uric acid, CRP, total bilirubin), and psychological measures (cognitive anxiety, somatic anxiety, and self-confidence assessed using CSAI-2). Measurements were taken at baseline and after the intervention period. The aim of the study is to determine whether e-TRE can improve physiological recovery and psychological readiness in combat sport athletes without negatively affecting performance-related variables.

調査の概要

詳細な説明

This study was designed to evaluate the effects of a 5-month early time-restricted eating (e-TRE) intervention on physiological and psychological outcomes in highly trained young male judo athletes. The study included 100 participants recruited from competitive judo teams in Tunisia. Participants were randomly assigned to either an e-TRE group or a control group in a 1:1 ratio.

The e-TRE group followed a structured 16:8 time-restricted eating protocol, consuming all daily energy intake within an 8-hour window from 07:00 to 15:00, followed by a 16-hour fasting period. During fasting hours, only non-caloric beverages were permitted. The control group maintained their habitual dietary intake and meal timing without any modifications. Both groups continued their regular judo training program, consisting of 5-6 training sessions per week, including technical drills, sparring (randori), and strength and conditioning exercises.

Anthropometric and biochemical measurements were collected at baseline (T0) and after the 5-month intervention (T1). Psychological assessments were conducted before monthly competitions throughout the study period. Blood samples were collected under standardized resting conditions and analyzed using validated enzymatic and immunoassay techniques.

Participants were required to meet strict inclusion criteria, including age 18-26 years, male sex, at least 3 years of judo training experience, and absence of metabolic, psychiatric, or chronic diseases. Exclusion criteria included use of medications or supplements affecting metabolism, prior experience with intermittent fasting, and conditions that could affect training or biomarker outcomes.

The study was approved by the Ethics Committee of the Higher Institute of Sport and Physical Education of Ksar Said, University of Manouba, Tunisia (approval No. 0171823; organization's unique protocol ID: ISSEP-2026-023) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment

Statistical analyses included repeated-measures ANOVA to assess group × time effects, with significance set at p < 0.05. Effect sizes were calculated using partial eta squared (η²).

研究の種類

介入

入学 (実際)

100

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Manouba
      • Manouba、Manouba、チュニジア、2009
        • Higher Institute of Sport and Physical Education of Manouba (ISSEP Manouba)

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • aged 19-26 years;
  • male judo players; c) with at least 3 years of judo training experience;
  • engaged in judo training 5-6 days per week; e) healthy, with no known chronic illnesses or conditions affecting metabolism, mental health, or physical performance;
  • willing to adhere to a 16:8 e-TRE protocol for the 5-month study period;
  • non-smokers, as smoking may affect anxiety levels and cardiovascular health;
  • not using any performance-enhancing drugs or supplements that could interfere with the study's measurements.

Exclusion Criteria:

  • current musculoskeletal injuries or conditions that could limit participation in training or affect muscle damage biomarkers;
  • diagnosed psychiatric disorders or current treatment for anxiety or mood disorders, as these could interfere with psychological assessments;
  • use of medications affecting metabolism, muscle recovery, or psychological state (e.g., corticosteroids, antidepressants);
  • prior experience with time-restricted eating or intermittent fasting within the past year, as prior adaptation could impact study outcomes;
  • dietary restrictions or practices (e.g., vegan or keto diet) that could affect nutrient intake or metabolic markers;
  • diagnosed sleep disorders or irregular sleep patterns, as sleep quality could impact both muscle recovery and psychological parameters;
  • inability to commit to the structured training program over the study period.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Early Time-Restricted Eating (e-TRE) Group
Participants in this group followed a 16:8 early time-restricted eating protocol for 5 months. Participants maintained their usual training program throughout the intervention period.
The intervention consisted of a 16:8 early time-restricted eating protocol applied for 5 months. Participants consumed all meals between 07:00 and 15:00, followed by a fasting period from 15:00 to 07:00 the next day. Only non-caloric beverages were allowed during fasting hours. Participants continued their regular judo training (5-6 sessions per week) without modifications. Dietary guidance was provided to support adherence to the eating schedule.
介入なし:Control Group
Participants in this group maintained their habitual dietary practices. They continued their regular judo training program throughout the 5-month study period.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Competitive Anxiety and Self-Confidence
時間枠:Baseline and 5 months (pre-intervention and post-intervention)

Competitive anxiety and self-confidence will be assessed using the Competitive State Anxiety Inventory-2 (CSAI-2). This validated questionnaire measures three dimensions of pre-competition psychological state: cognitive anxiety, somatic anxiety, and self-confidence. Scores will be used to evaluate changes in athletes' psychological readiness, emotional response to competition, and perceived self-efficacy.

The CSAI-2 consists of 27 items, divided into three subscales (9 items each). Each item is rated on a 4-point Likert scale ranging from 1 ("not at all") to 4 ("very much so"). Subscale scores are calculated by summing item responses, resulting in a score range of 9 to 36 for each dimension (cognitive anxiety, somatic anxiety, and self-confidence).

Measurements will be taken at baseline (T0) and post-intervention (T1) to determine the effect of early time-restricted eating on competitive anxiety and self-confidence in young judo athletes.

Baseline and 5 months (pre-intervention and post-intervention)
Creatine kinase (CK)
時間枠:Baseline and 5 months (pre-intervention and post-intervention)]
Creatine kinase (CK) will be used as a marker of muscle damage. Blood samples will be collected to assess changes in CK levels in response to the early time-restricted eating intervention. CK concentrations will be measured in U/L and compared between baseline (T0) and post-intervention (T1, 5 months) in judo athletes.
Baseline and 5 months (pre-intervention and post-intervention)]
Lactate dehydrogenase (LDH)
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
Lactate dehydrogenase (LDH) will be used as a biomarker of muscle damage. LDH will be measured in U/L to assess changes induced by early time-restricted eating between baseline and post-intervention in judo athletes.
Baseline and 5 months (pre-intervention and post-intervention)
Aspartate aminotransferase (AST)
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
Aspartate aminotransferase (AST) will be measured as an indirect marker of muscle damage and metabolic stress. AST levels will be assessed in U/L to evaluate changes from baseline to post-intervention following early time-restricted eating in judo athletes.
Baseline and 5 months (pre-intervention and post-intervention)
Alanine aminotransferase (ALT)
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
Alanine aminotransferase (ALT) will be assessed as a biomarker related to muscle stress. ALT levels will be measured in U/L to determine changes following early time-restricted eating between baseline and post-intervention in judo athletes.
Baseline and 5 months (pre-intervention and post-intervention)
Uric acid
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
Uric acid will be measured as a metabolic and oxidative stress biomarker. Serum uric acid will be assessed in µmol/L to evaluate changes induced by early time-restricted eating in judo athletes.
Baseline and 5 months (pre-intervention and post-intervention)
C-reactive protein (CRP)
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
C-reactive protein (CRP) will be used as a systemic inflammation biomarker. CRP levels will be measured in mg/L to assess inflammatory response changes following early time-restricted eating between baseline and post-intervention in judo athletes.
Baseline and 5 months (pre-intervention and post-intervention)
Total bilirubin
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
Total bilirubin will be measured as a marker of oxidative stress and heme metabolism. Serum bilirubin levels will be assessed in µmol/L to evaluate changes induced by early time-restricted eating in judo athletes between baseline and post-intervention.
Baseline and 5 months (pre-intervention and post-intervention)

二次結果の測定

結果測定
メジャーの説明
時間枠
Body Mass Index (BMI)
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
Body Mass Index (BMI) will be calculated as body weight in kilograms divided by height in meters squared (kg/m²). BMI will be used to assess changes in overall body composition status following early time-restricted eating.
Baseline and 5 months (pre-intervention and post-intervention)
Body fat percentage
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
Body fat percentage will be assessed as an indicator of relative adiposity. Body fat percentage will be expressed as a percentage (%) and measured to evaluate changes following the early time-restricted eating intervention.
Baseline and 5 months (pre-intervention and post-intervention)
Skeletal muscle mass
時間枠:Baseline and 5 months (pre-intervention and post-intervention)
Skeletal muscle mass will be assessed as an indicator of lean muscle tissue. Skeletal muscle mass will be measured in kilograms (kg) to evaluate changes induced by early time-restricted eating.
Baseline and 5 months (pre-intervention and post-intervention)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年1月1日

一次修了 (実際)

2026年1月20日

研究の完了 (実際)

2026年6月6日

試験登録日

最初に提出

2026年6月19日

QC基準を満たした最初の提出物

2026年6月25日

最初の投稿 (実際)

2026年6月26日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月26日

QC基準を満たした最後の更新が送信されました

2026年6月25日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • ISSEP-2026-023

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

There is no plan to share individual participant data. Only aggregate study results will be reported in publications and presentations.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する